Annual Current Liabilities
$17.46 M
+$4.43 M+33.96%
December 31, 2024
Summary
- As of March 5, 2025, JANX annual total current liabilities is $17.46 million, with the most recent change of +$4.43 million (+33.96%) on December 31, 2024.
- During the last 3 years, JANX annual current liabilities has risen by +$4.66 million (+36.43%).
- JANX annual current liabilities is now at all-time high.
Performance
JANX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$17.46 M
+$286.00 K+1.67%
December 31, 2024
Summary
- As of March 5, 2025, JANX quarterly total current liabilities is $17.46 million, with the most recent change of +$286.00 thousand (+1.67%) on December 31, 2024.
- Over the past year, JANX quarterly current liabilities has increased by +$286.00 thousand (+1.67%).
- JANX quarterly current liabilities is now -2.49% below its all-time high of $17.90 million, reached on June 30, 2023.
Performance
JANX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
JANX Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +34.0% | +1.7% |
| 3 y3 years | +36.4% | +1.7% |
| 5 y5 years | +277.3% | +1.7% |
JANX Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +36.4% | -2.5% | +64.6% |
| 5 y | 5-year | at high | +448.9% | -2.5% | +448.9% |
| alltime | all time | at high | +448.9% | -2.5% | +448.9% |
Janux Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $17.46 M(+34.0%) | $17.46 M(+1.7%) |
| Sep 2024 | - | $17.17 M(+48.7%) |
| Jun 2024 | - | $11.54 M(+8.8%) |
| Mar 2024 | - | $10.61 M(-18.6%) |
| Dec 2023 | $13.03 M(-21.0%) | $13.03 M(-9.9%) |
| Sep 2023 | - | $14.47 M(-19.2%) |
| Jun 2023 | - | $17.90 M(+11.1%) |
| Mar 2023 | - | $16.11 M(-2.4%) |
| Dec 2022 | $16.51 M | $16.51 M(+1.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $16.34 M(+25.7%) |
| Jun 2022 | - | $12.99 M(+3.8%) |
| Mar 2022 | - | $12.52 M(-2.2%) |
| Dec 2021 | $12.80 M(+302.3%) | $12.80 M(+2.6%) |
| Sep 2021 | - | $12.47 M(+35.5%) |
| Jun 2021 | - | $9.21 M(+33.5%) |
| Mar 2021 | - | $6.89 M(+116.7%) |
| Dec 2020 | $3.18 M(-31.3%) | $3.18 M |
| Dec 2019 | $4.63 M | - |
FAQ
- What is Janux Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Janux Therapeutics?
- What is Janux Therapeutics annual current liabilities year-on-year change?
- What is Janux Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Janux Therapeutics?
- What is Janux Therapeutics quarterly current liabilities year-on-year change?
What is Janux Therapeutics annual total current liabilities?
The current annual current liabilities of JANX is $17.46 M
What is the all time high annual current liabilities for Janux Therapeutics?
Janux Therapeutics all-time high annual total current liabilities is $17.46 M
What is Janux Therapeutics annual current liabilities year-on-year change?
Over the past year, JANX annual total current liabilities has changed by +$4.43 M (+33.96%)
What is Janux Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of JANX is $17.46 M
What is the all time high quarterly current liabilities for Janux Therapeutics?
Janux Therapeutics all-time high quarterly total current liabilities is $17.90 M
What is Janux Therapeutics quarterly current liabilities year-on-year change?
Over the past year, JANX quarterly total current liabilities has changed by +$286.00 K (+1.67%)